274 related articles for article (PubMed ID: 21731690)
1. Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals.
Bukh AR; Melchjorsen J; Offersen R; Jensen JM; Toft L; Støvring H; Ostergaard L; Tolstrup M; Søgaard OS
PLoS One; 2011; 6(6):e21275. PubMed ID: 21731690
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 RNA dysregulates the natural TLR response to subclinical endotoxemia in Kenyan female sex-workers.
Lester RT; Yao XD; Ball TB; McKinnon LR; Omange WR; Kaul R; Wachihi C; Jaoko W; Rosenthal KL; Plummer FA
PLoS One; 2009 May; 4(5):e5644. PubMed ID: 19461969
[TBL] [Abstract][Full Text] [Related]
3. Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.
Baroncelli S; Galluzzo CM; Pirillo MF; Mancini MG; Weimer LE; Andreotti M; Amici R; Vella S; Giuliano M; Palmisano L
J Clin Virol; 2009 Dec; 46(4):367-70. PubMed ID: 19782638
[TBL] [Abstract][Full Text] [Related]
4. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
5. A novel immunogen to modulate cytokine production and promote immune system reconstitution in HIV-AIDS.
Segal JL; Thompson JF; Charter RA
Am J Ther; 2012 Sep; 19(5):317-23. PubMed ID: 21822116
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory IL-37/SIGIRR axis is functionally compromised in HIV infection.
Samarani S; Abulkhir A; Amre D; Mehraj V; Tremblay C; Routy JP; Ahmad A
AIDS; 2019 Sep; 33(11):1693-1703. PubMed ID: 31149943
[TBL] [Abstract][Full Text] [Related]
7. Characterization of quantitative and functional innate immune parameters in HIV-1-infected Colombian children receiving stable highly active antiretroviral therapy.
Usuga X; Montoya CJ; Landay AL; Rugeles MT
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):348-57. PubMed ID: 19186348
[TBL] [Abstract][Full Text] [Related]
8. Pro-Inflammatory Cytokine Levels in HIV Infected and Uninfected Pregnant Women with and without Preeclampsia.
Maharaj NR; Phulukdaree A; Nagiah S; Ramkaran P; Tiloke C; Chuturgoon AA
PLoS One; 2017; 12(1):e0170063. PubMed ID: 28095491
[TBL] [Abstract][Full Text] [Related]
9. Naturally Occurring Subclinical Endotoxemia in Humans Alters Adaptive and Innate Immune Functions through Reduced MAPK and Increased STAT1 Phosphorylation.
Palmer CD; Romero-Tejeda M; Sirignano M; Sharma S; Allen TM; Altfeld M; Jost S
J Immunol; 2016 Jan; 196(2):668-77. PubMed ID: 26643479
[TBL] [Abstract][Full Text] [Related]
10. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
AIDS; 2000 Jan; 14(2):109-16. PubMed ID: 10708280
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
[TBL] [Abstract][Full Text] [Related]
12. Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up.
Hejdeman B; Leandersson AC; Fredriksson EL; Sandström E; Wahren B; Bratt G
HIV Med; 2003 Apr; 4(2):101-10. PubMed ID: 12702130
[TBL] [Abstract][Full Text] [Related]
13. A Low Frequency of IL-17-Producing CD8
Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
Front Immunol; 2018; 9():2502. PubMed ID: 30420859
[TBL] [Abstract][Full Text] [Related]
14. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
15. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
Tornero C; Alberola J; Tamarit A; Navarro D
Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients.
d'Ettorre G; Forcina G; Lichtner M; Mengoni F; D'Agostino C; Massetti AP; Mastroianni CM; Vullo V
AIDS; 2002 Jan; 16(2):181-8. PubMed ID: 11807301
[TBL] [Abstract][Full Text] [Related]
17. Increased Escherichia coli-induced interleukin-23 production by CD16+ monocytes correlates with systemic immune activation in untreated HIV-1-infected individuals.
Manuzak JA; Dillon SM; Lee EJ; Dong ZM; Hecht DK; Wilson CC
J Virol; 2013 Dec; 87(24):13252-62. PubMed ID: 24067979
[TBL] [Abstract][Full Text] [Related]
18. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
[TBL] [Abstract][Full Text] [Related]
19. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
Kaplan RC; Landay AL; Hodis HN; Gange SJ; Norris PJ; Young M; Anastos K; Tien PC; Xue X; Lazar J; Parrinello CM; Benning L; Tracy RP
J Acquir Immune Defic Syndr; 2012 Aug; 60(4):359-68. PubMed ID: 22592585
[TBL] [Abstract][Full Text] [Related]
20. Dynamic observation of IL-33 and its receptors in HIV patients who received HAART.
He B; Zheng L; Zhou H; He Y; Chen Z; Xiao S; Wang H; Ling Y; Zheng Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):73-77. PubMed ID: 28466817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
